Related Articles
00 / 00
-
Jeffrey M. Farma, MD, FACS, one of the editorial's authors
-
Jeffrey Farma is a surgical oncologist specializing in colorectal cancer, sarcomas, gastrointestinal stromal tumors, and skin cancer.
-
Cosmesis was rated as good in 81 percent of trials of conventional excision, 74.6 percent of trials of EBRT, and 97.6 percent of trials of brachytherapy.
-